CP
Centerbridge Partners, L.P.
13F filer · CIK 0001484836Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$38.1MU.S. long equity reported on 13F
Positions11 new · 3 closed
Net flow last quarter-$46.1MBuys minus sells
Top 10 positions weight100.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 20261 positions | |||||
| $38.1M | 100.00% | Not reported | New | Q2 2026 | |
| Q1 2026Reported May 15, 20263 positions | |||||
| $48.7M | 79.71% | 1.79% | Not reported | Q2 2025 | |
| GGOCOGoHealth, Inc. | $6.31M | 10.33% | 417985.00% | Not reported | Q3 2020 |
| $6.08M | 9.96% | 1.60% | New | Q1 2026 | |
| Q4 2025Reported Feb 17, 20262 positions | |||||
| $50.1M | 84.80% | 1.80% | +88.2% | Q2 2025 | |
| GGOCOGoHealth, Inc. | $8.99M | 15.20% | 417985.00% | Not reported | Q3 2020 |
| Q3 2025Reported Nov 14, 20253 positions | |||||
| $52.1M | 51.50% | 2.09% | -29.9% | Q4 2023 | |
| $27M | 26.67% | 0.95% | +18.4% | Q2 2025 | |
| GGOCOGoHealth, Inc. | $20.1M | 19.90% | 417985.00% | Not reported | Q3 2020 |
Premium opens every quarter this fund has filed